Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.02M | $197.0M | 10.12% | +765.6K | 2026-06-30 |
| Kynam Capital Management, LP | 8.05M | $175.0M | 9.03% | -- | 2026-06-30 |
| Goldman Sachs Group Inc | 5.86M | $128.0M | 6.57% | +864.5K | 2026-06-30 |
| State Street Corp | 5.66M | $123.0M | 6.35% | +1.23M | 2026-06-30 |
| Bank of America Corp | 4.05M | $88.0M | 4.54% | -204.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.93M | $85.0M | 4.41% | +105.3K | 2026-06-30 |
| Deerfield Management Company, L.P. | 3.78M | $82.0M | 4.24% | -- | 2026-06-30 |
| Eversept Partners, LP | 2.80M | $61.0M | 3.14% | -87.4K | 2026-06-30 |
| Geode Capital Management, LLC | 2.58M | $56.0M | 2.90% | +427.1K | 2026-06-30 |
| Hood River Capital Management LLC | 2.56M | $56.0M | 2.88% | +210.0K | 2026-06-30 |
